BioHarvest Sciences Inc. Common Stock
BHSTNASDAQBasic Materials● Active
$3.12
$-0.07(-2.19%)
Market Cap$54062424
P/E Ratio—
52W High$12.8
52W Low$3.06
BioHarvest Sciences Inc. Common Stock (BHST) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BHST · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($11.13M) | ($12.91M) | ($12.56M) | ($11.24M) | ($9.83M) |
| Depreciation & Amort. | $1.62M | $1.25M | $0.84M | $0.71M | $0.39M |
| Stock-Based Comp. | $0.60M | $0.60M | $0.56M | $1.35M | $3.37M |
| Change in Working Capital | ($1.94M) | ($0.56M) | $0.76M | ($0.31M) | ($0.10M) |
| Net Cash from Operations | ($7.23M) | ($6.68M) | ($8.52M) | ($9.24M) | ($6.79M) |
| Investing Activities | |||||
| Capital Expenditure | ($2.35M) | ($2.83M) | ($1.47M) | ($1.26M) | ($1.64M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($2.37M) | ($3.03M) | ($1.47M) | ($1.26M) | ($1.64M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $5.25M | $2.04M | $13.15M | $7.66M | ($0.33M) |
| Net Cash from Financing | $30.19M | $6.78M | $13.56M | $8.14M | $10.77M |
| Free Cash Flow | |||||
| Free Cash Flow | ($9.58M) | ($9.52M) | ($10.00M) | ($10.50M) | ($8.43M) |
| FCF Margin %(computed) | -27.76% | -37.79% | -78.88% | -190.92% | -401.24% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more BioHarvest Sciences Inc. Common Stock data
About BioHarvest Sciences Inc. Common Stock (BHST) Cash Flow Statement
BioHarvest Sciences Inc. Common Stock generated operating cash flow of ($0.01B) and free cash flow of ($0.01B) for 2025 — a FCF margin of -27.76%. Capital expenditure was ($0.00B).
Frequently asked questions
BHST · 4 questionsBioHarvest Sciences Inc. Common Stock generated free cash flow of ($0.01B) for 2025, down 0.7% year-over-year.
BHST free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10